FDA warns against pediatric use of Hospira’s potassium phosphates drug productFebruary 13th 2023
In a recent statement, the US Food and Drug Administration warned pharmacies and health care providers about unsafe aluminum levels for pediatric patients in Hospira’s unapproved potassium phosphates drug product.
Dietary therapies safe and efficient for treating drug-resistant epilepsyFebruary 7th 2023
While treatment discontinuation because of adverse events was more likely when taking dietary therapies for treating childhood drug-resistant epilepsy, reduction of seizures and seizure freedom were significantly more common.
Cleveland Clinic reexamines syphilis testing strategies after rise in casesFebruary 7th 2023
After observing an increase in the rate of syphilis cases, the Cleveland Clinic Ob/Gyn & Women’s Health Institute has partnered with the Center for Pediatric Infectious Diseases to evaluate the effectiveness of current testing strategies.